Therapeutics in Active Prostate Cancer Surveillance

NCT03365297 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

11

Enrollment

OTHER

Sponsor class

Conditions

Prostate Cancer

Interventions

DRUG: Apalutamide

Sponsor

CCTU- Cancer Theme

Collaborators

[object Object]